CrushSCI.com
Journal Selection & Manuscript Polishing Services
ONCOGENE journal cover Medicine
Back to journal directory

Review Cycle Records

ONCOGENE

Springer SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
236.2Average days
238Median days
92Fastest days
397Longest days
4032025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

131 days

UNC5B regulates epithelial-to-mesenchymal transition through a SRC-ZEB1 signaling axis to facilitate pancreatic cancer metastasis

AuthorsMuhammad Sadeqi Nezhad; Chris R. Harris; Orjola Prela; Wade Narrow; Mitchell Breitenbach; Lan Wang; Shubhrika Jain; Jennifer L. Becker; Buket Bagci; Yansheng Hao; Aram F. Hezel; Scott A. Gerber; Stephano Mello; Tracy Withers; Darren R. Carpizo

Affiliations1. Clinical and Translational Science Institute, Translational Biomedical Science, University of Rochester School of Medicine and Dentistry, Rochester, USA; 2. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA; 3. Department of Surgery, Division of Surgical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, USA; 4. Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, USA; 5. Center for Advanced Research Technologies, Genomics Research Center, University of Rochester Medical Center, Rochester, USA; 6. Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, USA; 7. Department of Biomedical Genetics, University of Rochester School of Medicine and Dentistry, Rochester, USA; 8. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA

Source PDF DOI Publisher page
210 days

The establishment of prostate-specific, SKP2 humanized mice by CRISPR knock-in method reveals neoplastic initiation and microenvironmental reprogramming

AuthorsLiankun Song; Yurong Song; Vyvyan Nguyen; Shan Xu; Kelly Ho; Altaf Mohammed; Robert H. Shoemaker; Bang H. Hoang; Jianhua Yu; Edward Uchio; Xiaolin Zi

Affiliations1. Department of Urology, University of California, Irvine, Orange, USA; 2. Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, USA; 3. Division of Cancer Prevention, National Cancer Institute, Rockville, USA; 4. Department of Orthopedic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, USA; 5. Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, USA; 6. Veterans Affairs Long Beach Healthcare System, Long Beach, USA

Source PDF DOI Publisher page
397 days

Oncogene SETDB1’s dual role: driving tumor progression and immune escape

AuthorsKiarash Salari; Jiaqing Hao; Ryan Jilek; Matthew Wells; Tianyue Li; Eleanor Johnson; Wendy Meng; Huiyaxin Wang; Ethan Zibble; Adam Allen; Jack Gilbert; Ryan McLerran; Emma Schuett; Claudia Oliva; Corinne E. Griguer; David K. Meyerholz; Melinda S. Yates; Henry L. Keen; Xiangbing Meng; Yiqin Xiong; Bing Li; Shujie Yang

Affiliations1. Department of Pathology, Carver College of Medicine, University of Iowa, Iowa, USA; 2. Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University, North Chicago, USA; 3. Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa, USA; 4. Department of Biological Science, Vanderbilt University, Nashville, USA; 5. Department of Radiation Oncology, University of Iowa, Iowa, USA; 6. Holden Comprehensive Cancer Center, University of Iowa, Iowa, USA; 7. Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, USA; 8. Iowa Institute of Human Genetics, Carver College of Medicine, University of Iowa, Iowa, USA; 9. Department of Pathology, Boston University, Boston, USA

Source PDF DOI Publisher page
155 days

OTUD6A promotes de novo pyrimidine synthesis by deubiquitinating and stabilizing CAD in cervical cancer

AuthorsLiming Liao; Lizhou Zeng; Yiliang Zhao; Zihao Guo; Tong Zeng; Ronghui Yang; Yu Xu; Xuesong Wu; Hongkun Wu; Mengyao Chen; Tao Zhu; Yapeng Ji; Binghui Li; Chuanzhen Yang

Affiliations1. Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Department of Biology, College of Life Sciences, Beijing Normal University, Beijing, China; 2. Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China; 3. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China; 4. Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China; 5. Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 6. Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 7. Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 8. Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China; 9. Department of Gynecological Radiotherapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China; 10. Department of Gynecological Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China; 11. School of Life Sciences, Westlake University, Hangzhou, China

Source PDF DOI Publisher page
238 days

p53 hotspot mutants attenuate CTL-mediated tumor cell killing through a novel ALKBH5-YTHDF3-PD-L1 pathway

AuthorsZhuan Ju; Xiang Zhang; Wenjie Zuo; Lu Zhang; Xin Fan; Chenxing Zhang; Xiaofang Zhang; Xiao Zhang; Yidi Wang; Ying Xing; Baile Zuo; Angang Yang; Rui Zhang; Huilong Yin

Affiliations1. State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Department of Immunology, Fourth Military Medical University, Xi’an, China; 2. Molecular Immunology and Immunotherapy Laboratory, School of Medical Technology, Henan Medical University, Xinxiang, China; 3. State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi’an, China; 4. Department of Endocrinology, Xi’an Daxing Hospital affiliated to Yan’an University, Xi’an, China; 5. Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China

Source PDF DOI Publisher page
239 days

LncRMRP drives bladder cancer invasion via a lactylation-driven positive feedback circuit

AuthorsYuting Gao; Chen Chen; Ruixin Sun; Yiwen Yao; Xueru Zhang; Wenqiang Quan; Jing Li; Ping Ji; Junlu Wu; Huarong Luo; Dong Li; Zujun Sun

Affiliations1. Department of Laboratory Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China; 2. Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China

Source PDF DOI Publisher page
272 days

PROTAC-mediated targeting of IKKβ and NR4A1 for AML therapy

AuthorsChandra K. Maharjan; Yi Liu; Yufeng Xiao; Bristy R. Podder; Tyler H. Montgomery; Lei Wang; Myung-Chul Kim; Zeng Jin; Seyedehalaleh Anvar; Tanzia Islam Tithi; Vivek M. Shastri; Alexandra M. Stevens; Ryan Kolb; Chen Zhao; Zhijian Qian; Jatinder K. Lamba; Guangrong Zheng; Weizhou Zhang

Affiliations1. Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, USA; 2. University of Florida Health Cancer Institute, University of Florida, Gainesville, USA; 3. Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, USA; 4. Genentech, South San Francisco, USA; 5. Laboratory of Clinical Pathology, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea; 6. Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida, Gainesville, USA; 7. Department of Pediatrics, Texas Children’s Hospital, Houston, USA; 8. Department of Pathology, Case Western Research University School of Medicine, Cleveland, USA; 9. Department of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, USA

Source PDF DOI Publisher page
331 days

TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions

AuthorsTakefumi Onodera; Shuichi Sakamoto; Shunichi Ohba; Manabu Kawada; Isao Momose

Affiliations1. Institute of Microbial Chemistry (BIKAKEN), Numazu, Japan; 2. Laboratory of Oncology, Institute of Microbial Chemistry (BIKAKEN), Shinagawa, Japan

Source PDF DOI Publisher page
356 days

Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis

AuthorsVenkatesh Varadharaj; Frank Leon; Nivedeta Krishna Kumar; Palanisamy Nallasamy; Pratima Raut; Annant Bir Kaur; Kirtana Arikath; Wyatt Petersen; Sanchita Rauth; Neelanjana Gayen; Zahraa Wajih Alsafwani; Poompozhil Mathivanan; Saravanakumar Marimuthu; Kavita Mallya; Madhu Bommideni; Jesse L. Cox; Geoffrey A. Talmon; Paul M. Grandgenett; Michael A. Hollingsworth; Dominick J. DiMaio; Jean L. Grem; Surinder K. Batra; Moorthy P. Ponnusamy

Affiliations1. Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, USA; 2. Department of Cancer Research, University of Nebraska Medical Center, Omaha, USA; 3. Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, USA; 4. Fred and Pamela Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA; 5. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, USA

Source PDF DOI Publisher page
168 days

HERC4 synergizes with USP16 to promote lung adenocarcinoma growth by augmenting protein translation via stabilizing RPS15

AuthorsQiuyun Jiang; Yiyang Liu; Wenshuang Sun; Ziyang Liu; Na Tao; Yunshu Zhao; Pingfei Li; Yujie Ou; Yuening Sun; Hongbiao Huang; Jia Yu; Wenhua Liang; Xinliang Mao

Affiliations1. The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University & Guangdong Provincial Key Laboratory of Protein Modification and Diseases, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China; 2. State Key Laboratory of Medical Molecular Biology, Department of Biochemistry and Molecular Biology, Haihe Laboratory of Cell Ecosystem, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China; 3. Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.